{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:42:23Z","timestamp":1768981343211,"version":"3.49.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p><jats:bold>Objectives:<\/jats:bold> Approximately 240 million individuals are infected with chronic hepatitis B virus (HBV) worldwide. HBV infection can develop into liver fibrosis. The mechanism of HBV-related liver fibrosis has not been fully understood, and there are few effective treatment options. The goal of this study was to use transcriptomics in conjunction with experimental validation to identify new targets to treat HBV-related liver fibrosis.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> To identify differentially expressed genes (DEGs), five liver tissues were collected from both healthy individuals and patients with chronic hepatitis B. NovoMagic and Java GSEA were used to screen DEGs and key genes, respectively. Immunocell infiltration analysis of RNA-seq data was, and the results were confirmed by Western blotting (WB), real-time quantitative polymerase chain reaction (RT-qPCR), and immunohistochemistry.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> We evaluated 1,105 genes with differential expression, and 462 and 643 genes showed down- and upregulation, respectively. The essential genes, such as tumor necrosis factor (TNF) receptor-associated factor-2 (TRAF2), were screened out of DEGs. TRAF2 expression was abnormally high in hepatic fibrosis in patients with hepatitis B compared with healthy controls. The degree of hepatic fibrosis and serum levels of glutamate transaminase (ALT), aspartate aminotransferase (AST), and total bilirubin (TBIL) were positively linked with TRAF2 expression. TRAF2 may be crucial in controlling T lymphocyte-mediated liver fibrosis.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our findings imply that TRAF2 is essential for HBV-induced liver fibrosis progression, and it may potentially be a promising target for the treatment of hepatic fibrosis in hepatitis B.<\/jats:p>","DOI":"10.3389\/fmolb.2023.1168250","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T05:00:25Z","timestamp":1680670825000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["TRAF2 as a key candidate gene in clinical hepatitis B-associated liver fibrosis"],"prefix":"10.3389","volume":"10","author":[{"given":"Cichun","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nianqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shifang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"721975","DOI":"10.3389\/fimmu.2021.721975","article-title":"HBV-specific CD8+ T-cell tolerance in the liver","volume":"12","author":"Baudi","year":"2021","journal-title":"Front. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1158\/1535-7163.MCT-18-0679","article-title":"CD3-Bispecific antibody therapy turns solid tumors into inflammatory sites but does not install protective memory","volume":"18","author":"Benonisson","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/gutjnl-2018-317959","article-title":"HBV antiviral immunity: Not all CD8 T cells are born equal","volume":"68","author":"Bertoletti","year":"2019","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/hep4.1835","article-title":"Traf2 and NCK interacting kinase is a critical regulator of procollagen I trafficking and hepatic fibrogenesis in mice","volume":"6","author":"Buchl","year":"2022","journal-title":"Hepatol. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.31236","article-title":"Lysyl oxidase (LOX) family members: Rationale and their potential as therapeutic targets for liver fibrosis","volume":"72","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2022-328428","DOI":"10.1136\/gutjnl-2022-328428","article-title":"Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences","author":"Chen","year":"2023","journal-title":"Gut"},{"key":"B7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jhep.2019.11.003","article-title":"Guidance for design and endpoints of clinical trials in chronic Hepatitis B - report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference\u2021","volume":"72","author":"Cornberg","year":"2020","journal-title":"J. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"114433","DOI":"10.1016\/j.jep.2021.114433","article-title":"Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-\u0263 and NF-kB mechanism","volume":"280","author":"de Souza Basso","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"965018","DOI":"10.3389\/fimmu.2022.965018","article-title":"Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection","volume":"13","author":"Du","year":"2022","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00210-022-02264-w","article-title":"Association of resveratrol with the suppression of TNF-\u03b1\/NF-kB\/iNOS\/HIF-1\u03b1 axis-mediated fibrosis and systemic hypertension in thioacetamide-induced liver injury","volume":"395","author":"Ebrahim","year":"2022","journal-title":"Naunyn. Schmiedeb. Arch. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","article-title":"Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches","volume":"11","author":"Fisicaro","year":"2020","journal-title":"Front. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jhep.2022.02.003","article-title":"Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis","volume":"77","author":"Fondevila","year":"2022","journal-title":"J. Hepatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s1074-7613(00)80295-2","article-title":"Intracellular inactivation of the Hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti","year":"1996","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/hep.32591","article-title":"Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis","volume":"76","author":"Harrington","year":"2022","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-022-00366-6","article-title":"Hepatic encephalopathy","volume":"8","author":"H\u00e4ussinger","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jhep.2020.09.011","article-title":"A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA","volume":"74","author":"Hirschfield","year":"2021","journal-title":"J. Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/gutjnl-2018-316644","article-title":"Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection","volume":"68","author":"Hoogeveen","year":"2019","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.10.035","article-title":"ALT is not associated with achieving subcirrhotic liver stiffness and HCC during entecavir therapy in HBV-related cirrhosis","author":"Kim","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/intimm\/dxy029","article-title":"TRAF2 and TRAF5 associated with the signal transducing receptor gp130 limit IL-6-driven transphosphorylation of JAK1 through the inhibition of proximal JAK-JAK interaction","volume":"30","author":"Kimura","year":"2018","journal-title":"Int. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.3390\/ijms232113010","article-title":"Structural insight into TNIK inhibition","volume":"23","author":"Kukimoto-Niino","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/hep.32181","article-title":"BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial","volume":"75","author":"Lawitz","year":"2022","journal-title":"Hepatology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1042\/CS20200031","article-title":"DNMT3b-mediated methylation of ZSWIM3 enhances inflammation in alcohol-induced liver injury via regulating TRAF2-mediated NF-\u03baB pathway","volume":"134","author":"Li","year":"2020","journal-title":"Clin. Sci. (Lond)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"114448","DOI":"10.1016\/j.addr.2022.114448","article-title":"Multiscale biomechanics and mechanotransduction from liver fibrosis to cancer","volume":"188","author":"Li","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver-linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/s0016-5085(99)70289-1","article-title":"Direct ex vivo analysis of Hepatitis B virus-specific CD8(+) T cells associated with the control of infection","volume":"117","author":"Maini","year":"1999","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2022-327059","DOI":"10.1136\/gutjnl-2022-327059","article-title":"Engineered anti-PDL1 with IFN\u03b1 targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance","author":"Meng","year":"2022","journal-title":"Gut"},{"key":"B29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.cmet.2022.05.004","article-title":"Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia","volume":"34","author":"Morrow","year":"2022","journal-title":"Cell Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3389\/fimmu.2018.01986","article-title":"Regulation of interleukin-6 receptor signaling by TNF receptor-associated factor 2 and 5 during differentiation of inflammatory CD4(+) T cells","volume":"9","author":"Nagashima","year":"2018","journal-title":"Front. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/hep.31771","article-title":"Liver-specific deletion of mouse Tm6sf2 promotes steatosis, fibrosis, and hepatocellular cancer","volume":"74","author":"Newberry","year":"2021","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J. Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41392-022-00953-9","article-title":"TRIM47 is a novel endothelial activation factor that aggravates lipopolysaccharide-induced acute lung injury in mice via K63-linked ubiquitination of TRAF2","volume":"7","author":"Qian","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic Hepatitis B virus infection: A systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3389\/fimmu.2018.01849","article-title":"Tumor necrosis factor receptor-associated factor regulation of nuclear factor \u03baB and mitogen-activated protein kinase pathways","volume":"9","author":"Shi","year":"2018","journal-title":"Front. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.3390\/cancers14164055","article-title":"TNF receptor associated factor 2 (TRAF2) signaling in cancer","volume":"14","author":"Siegmund","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"104748","DOI":"10.1016\/j.antiviral.2020.104748","article-title":"Adoptive T-cell therapy for HBV-associated HCC and HBV infection","volume":"176","author":"Tan","year":"2020","journal-title":"Antivir. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3390\/antiox11122383","article-title":"Cyanidin alleviated CCl4-induced acute liver injury by regulating the Nrf2 and NF-\u03baB signaling pathways","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1128\/JVI.78.11.5707-5719.2004","article-title":"Longitudinal analysis of CD8+ T cells specific for structural and nonstructural Hepatitis B virus proteins in patients with chronic Hepatitis B: Implications for immunotherapy","volume":"78","author":"Webster","year":"2004","journal-title":"J. Virol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"683506","DOI":"10.3389\/fmed.2021.683506","article-title":"Hepatic BRD4 is upregulated in liver fibrosis of various etiologies and positively correlated to fibrotic severity","volume":"8","author":"Wu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1002\/ctm2.591","article-title":"SMYD2-mediated TRAF2 methylation promotes the NF-\u03baB signaling pathways in inflammatory diseases","volume":"11","author":"Wu","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1038\/s41423-020-00583-7","article-title":"TRAF2 regulates T cell immunity by maintaining a Tpl2-ERK survival signaling axis in effector and memory CD8 T cells","volume":"18","author":"Xie","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.freeradbiomed.2020.12.018","article-title":"Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3\u03b2-mediated oxidative stress and IRE1\u03b1\/TRAF2\/JNK pathway","volume":"163","author":"Xu","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imr.12311","article-title":"Targeting signaling factors for degradation, an emerging mechanism for TRAF functions","volume":"266","author":"Yang","year":"2015","journal-title":"Immunol. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1073\/pnas.0913498107","article-title":"Immune effectors required for Hepatitis B virus clearance","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1002\/jmv.26969","article-title":"Polymorphisms of RIG-I-like receptor influence HBV clearance in Chinese Han population","volume":"93","author":"Yao","year":"2021","journal-title":"J. Med. Virol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/s0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.immuni.2022.01.018","article-title":"Tfh-cell-derived interleukin 21 sustains effector CD8(+) T cell responses during chronic viral infection","volume":"55","author":"Zander","year":"2022","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/gutjnl-2021-325915","article-title":"Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients","volume":"72","author":"Zhang","year":"2023","journal-title":"Gut"},{"key":"B51","doi-asserted-by":"publisher","first-page":"105420","DOI":"10.1016\/j.antiviral.2022.105420","article-title":"Interferon alpha facilitates anti-HBV cellular immune response in a B cell-dependent manner","volume":"207","author":"Zhong","year":"2022","journal-title":"Antivir. Res."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1168250\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T05:00:27Z","timestamp":1680670827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1168250\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":51,"alternative-id":["10.3389\/fmolb.2023.1168250"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1168250","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"article-number":"1168250"}}